Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach
Eslam B. Elkaeed, Mohamed M. Khalifa, Bshra A. Alsfouk, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1122-1122
Open Access | Times Cited: 10

Showing 10 citing articles:

Comprehensive structural and functional analysis of Patuletin as a potent inhibitor of SARS-CoV-2 targeting the RNA-dependent RNA polymerases
Ahmed M. Metwaly, Esmail M. El‐Fakharany, Aisha A. Alsfouk, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138424-138424
Closed Access | Times Cited: 4
Computer aided drug discovery (CADD) of a thieno[2,3- d ]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2369-2391
Open Access | Times Cited: 9
Repurposing FDA-Approved Drugs as Potential Inhibitors of SARS-CoV-2 PLpro: A Comprehensive Computational Study
Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, et al.
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 09, pp. 1209-1231
Closed Access | Times Cited: 2
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach
Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, et al.
Antiviral Therapy (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
A novel thieno[2,3‐d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor‐2: A story of computer‐aided drug discovery
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1247-1265
Closed Access | Times Cited: 6
Network pharmacology-integrated molecular docking analysis of phytocompounds of Caesalpinia pulcherrima (peacock flower) as potential anti-metastatic agents
Tan Hao Dong, Ashlyn Yau Wen Ning, Yin-Quan Tang
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1778-1794
Closed Access | Times Cited: 4
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
COVIDomics: Metabolomic Views on COVID-19
Armando Cevenini, Lucia Santorelli, Michele Costanzo
Metabolites (2024) Vol. 14, Iss. 12, pp. 702-702
Open Access | Times Cited: 1
Discovery of potential FDA-approved SARS-CoV-2 Papain-like protease inhibitors: A multi-phase in silico approach
Ahmed M. Metwaly, Eslam B. Elkaeed, Mohamed M. Khalifa, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 6
Open Access
Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assays
Ahmed M. Metwaly, Esmail M. El-Fakharany, Aisha A. Alsfouk, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0312866-e0312866
Open Access
Page 1

Scroll to top